The total return over the past 12 months is +22.96% vs. +16.94% for the S&P 500. So far it's up -10.52% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | +21.27% | +26.98% | +21.73% | +23.20% | N/A | N/A |
| Total Return CAGR | +22.96% | +28.94% | +24.06% | +24.37% | N/A | N/A |
| Revenue CAGR | +11.21% | +12.97% | +19.60% | +9.20% | N/A | N/A |
| Net Income CAGR | +11.60% | +16.22% | +38.23% | +10.13% | N/A | N/A |
| EPS CAGR | +11.66% | +20.16% | +74.32% | +10.04% | N/A | N/A |
| Free Cash Flow CAGR | +83.97% | +51.46% | +26.20% | +12.78% | N/A | N/A |
| Operating Cash Flow CAGR | (0.01%) | +21.48% | +26.61% | +12.09% | N/A | N/A |
| Dividends CAGR | (49.18%) | (17.01%) | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
IRadimed Corporation (IRMD)
| Year | Start price | End price | IRMD Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $97.28 | $86.47 | (10.52%) | +14.51% | (25.03%) |
| 2025 | $55.00 | $97.28 | +79.73% | +17.72% | +62.01% |
| 2024 | $47.47 | $55.00 | +17.01% | +24.89% | (7.88%) |
| 2023 | $28.29 | $47.47 | +75.05% | +26.19% | +48.86% |
| 2022 | $46.21 | $28.29 | (37.54%) | (18.17%) | (19.37%) |
| 2021 | $22.80 | $46.21 | +102.68% | +28.74% | +73.94% |
| 2020 | $23.38 | $22.80 | (2.48%) | +18.37% | (20.85%) |
| 2019 | $24.46 | $23.38 | (4.42%) | +31.22% | (35.64%) |
| 2018 | $15.15 | $24.46 | +61.45% | (4.56%) | +66.01% |
| 2017 | $11.10 | $15.15 | +36.49% | +21.70% | +14.79% |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
